We are pleased to announce that Exploration of Neuroprotective Therapy (ENT) has been accepted for indexing in Chemical Abstract Services (CAS).
CAS is a division of the American Chemical Society. It is the most authoritative and comprehensive source of chemical information. CAS intends to help scientists benefit from the published work of their colleagues around the world by monitoring, abstracting, and indexing the world's chemistry-related literature.
Acceptance for inclusion in CAS shows that the academic level and influence of ENT continue to improve. We appreciate the recognition and will continue to persist in our original intention to develop a high-quality academic journal. Road ahead is long and hard. Persist, we will succeed!
COPE Membership of Exploration of Neuroprotective Therapy Approved
ENT’s Editorial Board Member is actively promoting the journal’s Scopus inclusion news
Exploration of Neuroprotective Therapy accepted for Scopus
ENT promoted in the International Congress on Neurodegenerative Diseases ICND2024